Infections in the diabetic foot

Munro, N.; Rich, Nicole E.; McIntosh, C.; Foster, Ali; Edmonds, Michael

doi:10.1177/14746514030030020901

Cited by 4 publications

(3 citation statements)

References 28 publications

(18 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…9 The management strategies in the infected diabetic foot have recently been reviewed in this Journal and include debridement, mechanical relief, wound dressing and healing stimulation, antimicrobial therapy, vascular interventions and appropriate metabolic management. 10 With regard to antibiotic therapy, until recently there were few therapeutic options for MRSA infections. 11 Vancomycin, a glycopeptide, has been the main treatment for MRSA.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Diabetic MRSA foot infection — role of linezolid therapy

Turner¹,

Hakeem²,

Lockman³

et al. 2004

Diabetes & Vascular Disease

View full text Add to dashboard Cite

D iabetic foot ulceration is common and disabling, often leading to amputation of the leg. Foot ulcers commonly become infected and MRSA infection is becoming more prevalent. MRSA is becoming a major public health problem because of its associated high morbidity and mortality, due to difficulty in its eradication with conventional antibiotics. Although vancomycin is the present mainstay of treatment of MRSA infection, a recently introduced antibiotic, linezolid may have benefits. Linezolid can be given orally, obviating the need for i.v. monitoring and offering potential savings in hospital costs with earlier discharge because of its suitability for out-patient eradication of MRSA. Br J Diabetes Vasc Dis 2004;4:44-6

show abstract

Section: Discussionmentioning

confidence: 99%

“…12,13 Clindomycin, co-trimoxazole, fluoroquinolone, minocycline and rifampicin may be useful in mild-to-moderate MRSA infections caused by strains susceptible to these agents. 10 To reduce the possibility of antibiotic resistance, two agents should be used.…”

Section: Discussionmentioning

confidence: 99%

Diabetic MRSA foot infection — role of linezolid therapy

Turner¹,

Hakeem²,

Lockman³

et al. 2004

Diabetes & Vascular Disease

View full text Add to dashboard Cite

show abstract

“…Several reviews, consensus documents and guidelines including those from NICE (Clinical Guidance CG010 6 and CG15 7 ) in 2004, have stressed the importance of early recognition of the 'at-risk' foot. 8…”

Section: Introductionmentioning

confidence: 99%